Investors – Vallon Pharmaceuticals

Vallon Pharmaceuticals and GRI Bio Enter into Merger Agreement with Goal of Advancing Innovative Pipeline of NKT Cell Regulators

We hosted a joint webcast on December 14, 2022 – Access the Webcast Replay Here

Sign Up for Updates

ADAIR is an investigational new drug product and has not yet been approved by the FDA. All trademarks shown are the property of their respective owners.